Perspectum Group PLC

Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.

Perspectum Group has filed proposed terms for a $75 million U.S. IPO. The firm sells imaging software and services for various serious organ disease monitoring and diagnosis use cases.

News for Perspectum Group PLC Stock (SCAN)